Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Janet A Dunn, et al. on X:
“Cowabunga!
Riding Breast Cancer’s Biggest Data’s Wave from Literature.
MAMMO-50: Less frequent vs annual mammography ONLY in selected BC pts (83% ER+). Caution in high-risk subgroups!
Nice wave for luminal, but still watching triple neg/HER2+ surf conditions!”
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial.
Authors: Janet A Dunn, et al.
